EP0904538A4 - Benutzung von anti-cholesterol-antikorpern in einer methode zur diagnose und behandlung von atherosklerose - Google Patents

Benutzung von anti-cholesterol-antikorpern in einer methode zur diagnose und behandlung von atherosklerose

Info

Publication number
EP0904538A4
EP0904538A4 EP96944237A EP96944237A EP0904538A4 EP 0904538 A4 EP0904538 A4 EP 0904538A4 EP 96944237 A EP96944237 A EP 96944237A EP 96944237 A EP96944237 A EP 96944237A EP 0904538 A4 EP0904538 A4 EP 0904538A4
Authority
EP
European Patent Office
Prior art keywords
atherosclerosis
diagnosis
treatment
cholesterol antibodies
cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP96944237A
Other languages
English (en)
French (fr)
Other versions
EP0904538A1 (de
Inventor
Jan Dijkstra
Glenn M Swartz Jr
Jacinta Aniagolu
Carol A Nacy
Shawn J Green
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Casi Pharmaceuticals Inc
Original Assignee
Entremed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entremed Inc filed Critical Entremed Inc
Publication of EP0904538A1 publication Critical patent/EP0904538A1/de
Publication of EP0904538A4 publication Critical patent/EP0904538A4/de
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP96944237A 1995-12-05 1996-12-05 Benutzung von anti-cholesterol-antikorpern in einer methode zur diagnose und behandlung von atherosklerose Ceased EP0904538A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US759569 1985-07-26
US820395P 1995-12-05 1995-12-05
US8203P 1995-12-05
US75956996A 1996-12-04 1996-12-04
PCT/US1996/019381 WO1997021099A1 (en) 1995-12-05 1996-12-05 Method of diagnosis and treatment of atherosclerosis using anti-cholesterol antibodies

Publications (2)

Publication Number Publication Date
EP0904538A1 EP0904538A1 (de) 1999-03-31
EP0904538A4 true EP0904538A4 (de) 2001-04-11

Family

ID=26677928

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96944237A Ceased EP0904538A4 (de) 1995-12-05 1996-12-05 Benutzung von anti-cholesterol-antikorpern in einer methode zur diagnose und behandlung von atherosklerose

Country Status (5)

Country Link
EP (1) EP0904538A4 (de)
JP (1) JP2002504225A (de)
AU (1) AU713531B2 (de)
CA (1) CA2239092A1 (de)
WO (1) WO1997021099A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492185B1 (en) * 1998-01-16 2002-12-10 Abbott Laboratories Immunoassay for detection of very low density lipoprotein and antibodies useful therefor
AUPR458201A0 (en) 2001-04-23 2001-05-24 Commonwealth Scientific And Industrial Research Organisation Fluid properties evaluation
WO2005023831A1 (en) * 2003-09-05 2005-03-17 The Scripps Research Institute Detection of cholesterol ozonation products
AU2004270702B2 (en) * 2003-09-05 2009-08-06 The Scripps Research Institute Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases
CA2465427A1 (en) * 2004-04-28 2005-10-28 Imi International Medical Innovations Inc. Direct assay of cholesterol in skin samples removed by tape stripping

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018067A1 (en) * 1992-03-06 1993-09-16 Abbott Laboratories Immunocapture assay for direct quantitation of specific lipoprotein cholesterol levels
WO1994023302A1 (en) * 1993-04-07 1994-10-13 The Australian National University Immunological assay of oxidatively modified human low density lipoproteins in plasma
EP0621284A1 (de) * 1992-08-14 1994-10-26 Shino-Test Corporation PEPTIDE BESTEHEND AUS AMINOSÄURESEQUENZEN AUS ENTWEDER LIPOPROTEIN(a) ODER APOLIPOPROTEIN(a), ANTIKÖRPER, DIE DIESE AMINOSÄURESEQUENZEN ERKENNEN UND MESSVERFAHREN MIT DIESEN ANTIKÖRPERN

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000592A1 (en) * 1992-06-26 1994-01-06 Exocell, Inc. Monoclonal antibodies against glycated low density lipoprotein

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018067A1 (en) * 1992-03-06 1993-09-16 Abbott Laboratories Immunocapture assay for direct quantitation of specific lipoprotein cholesterol levels
EP0621284A1 (de) * 1992-08-14 1994-10-26 Shino-Test Corporation PEPTIDE BESTEHEND AUS AMINOSÄURESEQUENZEN AUS ENTWEDER LIPOPROTEIN(a) ODER APOLIPOPROTEIN(a), ANTIKÖRPER, DIE DIESE AMINOSÄURESEQUENZEN ERKENNEN UND MESSVERFAHREN MIT DIESEN ANTIKÖRPERN
WO1994023302A1 (en) * 1993-04-07 1994-10-13 The Australian National University Immunological assay of oxidatively modified human low density lipoproteins in plasma

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9721099A1 *
SWARTZ GM ET AL: "Antibodies to cholesterol", PROC. NATL. ACAD. SCI., vol. 85, March 1988 (1988-03-01), USA, pages 1902 - 1906, XP000942042 *

Also Published As

Publication number Publication date
EP0904538A1 (de) 1999-03-31
AU713531B2 (en) 1999-12-02
AU1409797A (en) 1997-06-27
WO1997021099A1 (en) 1997-06-12
JP2002504225A (ja) 2002-02-05
CA2239092A1 (en) 1997-06-12

Similar Documents

Publication Publication Date Title
US5719329B1 (en) Ultrasonic measuring system and method of operation
IL124757A0 (en) Ultrasonic system and method
GB9711208D0 (en) Therapeutic structure and method
EP0804260A4 (de) Eversionskathetersystem und methode zu seiner anwendung
CZ40898A3 (cs) Zařízení a způsob podmíněného přístupu
PL314640A1 (en) Method of vaccinating against coccodiosis
AU5326496A (en) Acoustic imaging catheter and method of operation
KR100233880B1 (en) Forming method of bolt and bolt forming device
IL115538A (en) Method and system for determination of the pressure-volume relationship of the heart
GB9509897D0 (en) Apparatus for and method of condition diagnosis
PL322652A1 (en) Compounds of pyrolydinylohydroxamic acid and method of obtaining them
EP0777426A4 (de) Mokassinausführung und verfahren zu seiner herstellung
GB9503119D0 (en) Medication and apparatus and method of applying medication
IL119354A0 (en) Method and device for treatment of the brainstem
EP0904538A4 (de) Benutzung von anti-cholesterol-antikorpern in einer methode zur diagnose und behandlung von atherosklerose
PL325515A1 (en) Pultry egg and method of producing same
EP0828507A4 (de) Verfahren zur behandlung von schmerz
PL327603A1 (en) Method of aminocarbonylating benzazepins and benzodiazepins
GB9507825D0 (en) Method of treatment
IL123747A (en) System and method of three-dimensional imaging
GB2304209B (en) Processor system and method of starting-up a processor system
PL324867A1 (en) Method of obtaining cyclopropanocarboxylic acids and intermediate compounds
GB9415902D0 (en) Method of treatment
ZA969563B (en) Cleaning concentrates and method of preparation
GB9407335D0 (en) Method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980612

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 20010228

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB IT

RIC1 Information provided on ipc code assigned before grant

Free format text: 7G 01N 33/53 A, 7G 01N 33/92 B

17Q First examination report despatched

Effective date: 20010713

RTI1 Title (correction)

Free format text: METHOD OF DIAGNOSIS OF ATHEROSCLEROSIS USING ANTI-CHOLESTEROL ANTIBODIES

RTI1 Title (correction)

Free format text: METHOD OF DIAGNOSIS OF ATHEROSCLEROSIS USING ANTI-CHOLESTEROL ANTIBODIES

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

RTI1 Title (correction)

Free format text: METHOD OF DIAGNOSIS OF ATHEROSCLEROSIS USING ANTI-CHOLESTEROL ANTIBODIES

RTI1 Title (correction)

Free format text: METHOD OF DIAGNOSIS OF ATHEROSCLEROSIS USING ANTI-CHOLESTEROL ANTIBODIES

RTI1 Title (correction)

Free format text: METHOD OF DIAGNOSIS OF ATHEROSCLEROSIS USING ANTI-CHOLESTEROL ANTIBODIES

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20020809